Why "labour shortages" don't really exist
Use the term, and you are almost always a bad economist or a special pleader ...
Team, Inc. Announces Refinancing Transaction
Lowers Cost of Capital and Terms Out Maturities Lowers Cost of Capital and Terms Out Maturities ...
Battery Management System Market Set to Reach USD 56.4 Billion by 2034 Driven by Rising EV Demand | Latest Report by Transparency Market Research, Inc.
Wilmington, Delaware, Transparency Market Research Inc. -, March 13, 2025 ( GLOBE NEWSWIRE ) -- The global battery management system market was valued at US$ 9.2 Bn in 2023 and is projected to grow at a CAGR of 17.6% from 2024 to 2034, reaching US$ 56.4 Bn by 2034.
United Lithium Receives Positive Mineralogical Tests from its Bergby Project, Sweden - United Lithium ( OTC:ULTHF )
VANCOUVER, British Columbia, March 13, 2025 ( GLOBE NEWSWIRE ) -- United Lithium Corp. ( "United Lithium" or the "Company" ) ( CSE: ULTH. OTCQX: ULTHF.
Kraken Robotics Expands U.S. Footprint with Acquisition of 3D at Depth
A Leader in Underwater LiDAR Services, 3D at Depth Brings Expertise and Strong Customer Relationships A Leader in Underwater LiDAR Services, 3D at Depth Brings Expertise and Strong Customer Relationships ...
ECARX Highlights Q4 2024 EBITDA Breakeven, Positive EBITDA 2025 Outlook, and Global Expansion at Investor Day 2025
SHANGHAI, March 13, 2025 ( GLOBE NEWSWIRE ) -- ECARX Holdings Inc. ( Nasdaq: ECX ) ( "ECARX" or the "Company" ) , a global mobility tech provider, today showcased its significant financial milestones and strategic initiatives from 2024 while outlining its vision to drive growth going forward at ...
Blade Air Mobility Announces Fourth Quarter 2024 Results - Blade Air Mobility ( NASDAQ:BLDE )
Full-year net loss improved by $28.8 million versus the prior year to $ ( 27.3 ) million in FY 2024; Adjusted EBITDA improved by $17.8 million versus the prior year to $1.2 million in FY 2024 ( 1 ) Full-year Passenger Segment Adjusted EBITDA of $3.6 million in 2024 represents an $8.6 ...
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update • Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential milestones of up to about $2.1 billion plus royalties on sales upon commercialization • ...
ProQR Announces Year End 2024 Operating and Financial Results - ProQR Therapeutics ( NASDAQ:PRQR )
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases






